In this Webinar we discuss:
Review advanced immune-based approaches in acute myeloid leukemia that combine chemotherapy with checkpoint therapy
Explore relevant biomarker strategies associated with these approaches
See how single-cell cytokine analysis system and PSI demonstrate that specific cytokine potency contributors correlate with overall survival
